Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
Clinical trial NCT07654855 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07654855
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-01
- Primary completion
- 2032-01-29
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.